Brain natriuretic peptide in the management of heart failure - The versatile neurohormone

被引:62
作者
de Denus, S
Williamson, DR
机构
[1] Univ Montreal, Hop Sacre Coeur, Fac Pharm, Montreal, PQ H4J 1C5, Canada
[2] Univ Sci Philadelphia, Coll Pharm, Philadelphia, PA USA
关键词
brain natriuretic peptide; congestive heart failure; nesiritide;
D O I
10.1378/chest.125.2.652
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Brain natriuretic peptide (BNP), also called B-type natriuretic peptide, is a member of a family of structurally related hormones, the natriuretic peptides. Current data suggest that measurement of BNP plasma concentrations is a useful tool in the diagnosis of acute heart failure in patients presenting to an emergency department with acute dyspnea. Furthermore, BNP constitutes a promising new marker of prognosis after an acute coronary syndrome episode and in patients with chronic heart failure. Nesiritide, the human recombinant form of BNP, is a new vasodilator used in the treatment of acute heart failure that has several potential advantages over current drug therapy.
引用
收藏
页码:652 / 668
页数:17
相关论文
共 129 条
  • [1] Changes in brain natriuretic peptide and norepinephrine over time and mortality and morbidity in the Valsartan Heart Failure Trial (Val-HeFT)
    Anand, IS
    Fisher, LD
    Chiang, YT
    Latini, R
    Masson, S
    Maggioni, AP
    Glazer, RD
    Tognoni, G
    Cohn, JN
    [J]. CIRCULATION, 2003, 107 (09) : 1278 - 1283
  • [2] Plasma concentrations of atrial, brain, and C-type natriuretic peptides and endothelin-1 in patients with chronic respiratory diseases
    Ando, T
    Ogawa, K
    Yamaki, K
    Hara, M
    Takagi, K
    [J]. CHEST, 1996, 110 (02) : 462 - 468
  • [3] [Anonymous], 1993, CIRCULATION
  • [4] Plasma brain natriuretic peptide concentrations predict survival after acute myocardial infarction
    Arakawa, N
    Nakamura, M
    Aoki, H
    Hiramori, K
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1996, 27 (07) : 1656 - 1661
  • [5] Intravenous Nesiritide (Human B-Type natriuretic peptide) reduces plasma endothelin-1 levels in patients with decompensated congestive heart failure
    Aronson, D
    Burger, AJ
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2002, 90 (04) : 435 - +
  • [6] Elevated plasma brain natriuretic peptide levels in chronic respiratory failure with cor pulmonale
    Bando, M
    Ishii, Y
    Sugiyama, Y
    Kitamura, S
    [J]. RESPIRATORY MEDICINE, 1999, 93 (07) : 507 - 514
  • [7] B-type natriuretic peptide predicts sudden death in patients with chronic heart failure
    Berger, R
    Huelsman, M
    Strecker, K
    Bojic, A
    Moser, P
    Stanek, B
    Pacher, R
    [J]. CIRCULATION, 2002, 105 (20) : 2392 - 2397
  • [8] Effects of intravenous brain natriuretic peptide on regional sympathetic activity in patients with chronic heart failure as compared with healthy control subjects
    Brunner-La Rocca, HP
    Kaye, DM
    Woods, RL
    Hastings, J
    Esler, MD
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2001, 37 (05) : 1221 - 1227
  • [9] Within-patient comparison of effects of different dosages of enalapril on functional capacity and neurohormone levels in patients with chronic heart failure
    Brunner-La Rocca, HP
    Weilenmann, D
    Kiowski, W
    Maly, FE
    Candinas, R
    Follath, F
    [J]. AMERICAN HEART JOURNAL, 1999, 138 (04) : 654 - 662
  • [10] Effect of nesiritide (B-type natriuretic peptide) and dobutamine on ventricular arrhythmias in the treatment of patients with acutely decompensated congestive heart failure: The PRECEDENT study
    Burger, AJ
    Horton, DP
    LeJemtel, T
    Ghali, JK
    Torre, G
    Dennish, G
    Koren, M
    Dinerman, J
    Silver, M
    Cheng, ML
    Elkayam, U
    [J]. AMERICAN HEART JOURNAL, 2002, 144 (06) : 1102 - 1108